Boothbay Fund Management »

Capricor Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 169k 7.21
2025-06-30 $7.4M 747k 9.93
2025-03-31 $1.2M 128k 9.49
2024-12-31 $2.7M 193k 13.80
2024-09-30 $4.0M 263k 15.21

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Capricor Therapeutics

BlackRock
Vanguard Group
Susquehanna International
Citadel Advisors
Geode Capital Management
Caption Management
State Street Corporation
LMR Partners
J. Goldman & Co
Morgan Stanley
Pier Capital
DG Capital Management
Ikarian Capital
Millennium Management
National Bank Of Canada /fi/

View all funds holding Capricor Therapeutics